Inclusion body myositis in twins

Neurology ◽  
1998 ◽  
Vol 51 (2) ◽  
pp. 598-600 ◽  
Author(s):  
Anthony A. Amato ◽  
Robert T. Shebert

Sporadic inclusion body myositis (s-IBM) is characterized by late onset of slowly progressive weakness that involves the quadriceps and volar forearm muscles early in the course of the disease. There are hereditary forms of inclusion body myopathy (h-IBM) that histologically resemble s-IBM. The lack of inflammation on biopsy and the different ages at onset and patterns of muscle weakness distinguish s-IBM from h-IBM. We report twin brothers with the typical clinical and histologic features of s-IBM. The occurrence of s-IBM in these twins suggests the possibility of a genetic susceptibility to developing s-IBM.

2016 ◽  
Vol 55 (23) ◽  
pp. 3521-3524 ◽  
Author(s):  
Yuichi Suwa ◽  
Naoki Suzuki ◽  
Temma Soga ◽  
Ryuhei Harada ◽  
Aya Shibui ◽  
...  

2019 ◽  
Vol 17 (2) ◽  
pp. 193-195
Author(s):  
Marco Orsini ◽  
Mariana Pimentel Mello ◽  
Marcos RG de Freitas ◽  
Osvaldo JM Nascimento

Familial inclusion body myositis (FIBM) is extremely rare. The disease is characterized by relatively late onset, selective and early involvement of quadriceps, forearm and finger flexors, only mild increase of serum creatine kinase CK level, frequent rimmed vacuoles in muscle histopathology with substantial inflammatory cell infiltration. The combination of clinical, histological, immunopathological and immunogenetic features indicates that these patients have a disease identical to sporadic inclusion body myositis.


2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
Danijela Levacic ◽  
Leema Reddy Peddareddygari ◽  
David Nochlin ◽  
Leroy R. Sharer ◽  
Raji P. Grewal

Sporadic inclusion-body myositis (s-IBM) is a myopathy that is characterized by progressive weakness and muscle pathology demonstrating inflammation and rimmed vacuoles. In addition, similar to the pathology observed in the brains of patients with Alzheimer’s disease, the deposition of beta-amyloid and phosphorylated tau proteins in muscle fibers has been reported. These shared pathologic features have prompted hypotheses suggesting a shared etiology of these two conditions. We report a case of a 73-year-old woman initially diagnosed with s-IBM who later developed Alzheimer’s disease.


Biomolecules ◽  
2019 ◽  
Vol 9 (1) ◽  
pp. 15 ◽  
Author(s):  
Boel De Paepe

The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy. Its complex pathogenesis includes degenerative, inflammatory and mitochondrial aspects. However, which of those mechanisms are cause and which effect, as well as their interrelations, remain partly obscured to this day. In this review the nature of the mitochondrial dysregulation in IBM muscle is explored and comparison is made with other muscle disorders. Mitochondrial alterations in IBM are evidenced by histological and serum biomarkers. Muscular mitochondrial dynamics is disturbed, with deregulated organelle fusion leading to subsequent morphological alterations and muscle displays abnormal mitophagy. The tissue increases mitochondrial content in an attempt to compensate dysfunction, yet mitochondrial DNA (mtDNA) alterations and mild mtDNA depletion are also present. Oxidative phosphorylation defects have repeatedly been shown, most notably a reduction in complex IV activities and levels of mitokines and regulatory RNAs are perturbed. Based on the cumulating evidence of mitochondrial abnormality as a disease contributor, it is therefore warranted to regard IBM as a mitochondrial disease, offering a feasible therapeutic target to be developed for this yet untreatable condition.


1996 ◽  
Vol 40 (2) ◽  
pp. 264-264 ◽  
Author(s):  
Valerie Askanas ◽  
W. King ◽  
Massimiliano Mirabella ◽  
Janis McFerrin ◽  
Karl H. Weisgraber ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document